Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.

Identifieur interne : 000610 ( Main/Exploration ); précédent : 000609; suivant : 000611

Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.

Auteurs : Duarte Gouveia [France] ; Lucia Grenga [France] ; Jean-Charles Gaillard [France] ; Fabrice Gallais [France] ; Laurent Bellanger [France] ; Olivier Pible [France] ; Jean Armengaud [France]

Source :

RBID : pubmed:32462744

Descripteurs français

English descriptors

Abstract

Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a crucial tool for fighting the COVID-19 pandemic. This dataset brief presents the exploration of a shotgun proteomics dataset acquired on SARS-CoV-2 infected Vero cells. Proteins from inactivated virus samples were extracted, digested with trypsin, and the resulting peptides were identified by data-dependent acquisition tandem mass spectrometry. The 101 peptides reporting for six viral proteins were specifically analyzed in terms of their analytical characteristics, species specificity and conservation, and their proneness to structural modifications. Based on these results, a shortlist of 14 peptides from the N, S, and M main structural proteins that could be used for targeted mass-spectrometry method development and diagnostic of the new SARS-CoV-2 is proposed and the best candidates are commented.

DOI: 10.1002/pmic.202000107
PubMed: 32462744
PubMed Central: PMC7267140


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.</title>
<author>
<name sortKey="Gouveia, Duarte" sort="Gouveia, Duarte" uniqKey="Gouveia D" first="Duarte" last="Gouveia">Duarte Gouveia</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Grenga, Lucia" sort="Grenga, Lucia" uniqKey="Grenga L" first="Lucia" last="Grenga">Lucia Grenga</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gaillard, Jean Charles" sort="Gaillard, Jean Charles" uniqKey="Gaillard J" first="Jean-Charles" last="Gaillard">Jean-Charles Gaillard</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gallais, Fabrice" sort="Gallais, Fabrice" uniqKey="Gallais F" first="Fabrice" last="Gallais">Fabrice Gallais</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bellanger, Laurent" sort="Bellanger, Laurent" uniqKey="Bellanger L" first="Laurent" last="Bellanger">Laurent Bellanger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pible, Olivier" sort="Pible, Olivier" uniqKey="Pible O" first="Olivier" last="Pible">Olivier Pible</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Armengaud, Jean" sort="Armengaud, Jean" uniqKey="Armengaud J" first="Jean" last="Armengaud">Jean Armengaud</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32462744</idno>
<idno type="pmid">32462744</idno>
<idno type="doi">10.1002/pmic.202000107</idno>
<idno type="pmc">PMC7267140</idno>
<idno type="wicri:Area/Main/Corpus">001081</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001081</idno>
<idno type="wicri:Area/Main/Curation">001081</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001081</idno>
<idno type="wicri:Area/Main/Exploration">001081</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.</title>
<author>
<name sortKey="Gouveia, Duarte" sort="Gouveia, Duarte" uniqKey="Gouveia D" first="Duarte" last="Gouveia">Duarte Gouveia</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Grenga, Lucia" sort="Grenga, Lucia" uniqKey="Grenga L" first="Lucia" last="Grenga">Lucia Grenga</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gaillard, Jean Charles" sort="Gaillard, Jean Charles" uniqKey="Gaillard J" first="Jean-Charles" last="Gaillard">Jean-Charles Gaillard</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gallais, Fabrice" sort="Gallais, Fabrice" uniqKey="Gallais F" first="Fabrice" last="Gallais">Fabrice Gallais</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bellanger, Laurent" sort="Bellanger, Laurent" uniqKey="Bellanger L" first="Laurent" last="Bellanger">Laurent Bellanger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pible, Olivier" sort="Pible, Olivier" uniqKey="Pible O" first="Olivier" last="Pible">Olivier Pible</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Armengaud, Jean" sort="Armengaud, Jean" uniqKey="Armengaud J" first="Jean" last="Armengaud">Jean Armengaud</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Proteomics</title>
<idno type="eISSN">1615-9861</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence (MeSH)</term>
<term>Animals (MeSH)</term>
<term>Betacoronavirus (chemistry)</term>
<term>Betacoronavirus (isolation & purification)</term>
<term>Chlorocebus aethiops (MeSH)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (virology)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Peptides (analysis)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Proteomics (MeSH)</term>
<term>Tandem Mass Spectrometry (MeSH)</term>
<term>Vero Cells (MeSH)</term>
<term>Viral Proteins (analysis)</term>
<term>Viral Structural Proteins (analysis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Betacoronavirus (composition chimique)</term>
<term>Betacoronavirus (isolement et purification)</term>
<term>Cellules Vero (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Pandémies (MeSH)</term>
<term>Peptides (analyse)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Protéines virales (analyse)</term>
<term>Protéines virales structurales (analyse)</term>
<term>Protéomique (MeSH)</term>
<term>Spectrométrie de masse en tandem (MeSH)</term>
<term>Séquence d'acides aminés (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Peptides</term>
<term>Viral Proteins</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Peptides</term>
<term>Protéines virales</term>
<term>Protéines virales structurales</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Proteomics</term>
<term>Tandem Mass Spectrometry</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules Vero</term>
<term>Humains</term>
<term>Pandémies</term>
<term>Protéomique</term>
<term>Spectrométrie de masse en tandem</term>
<term>Séquence d'acides aminés</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a crucial tool for fighting the COVID-19 pandemic. This dataset brief presents the exploration of a shotgun proteomics dataset acquired on SARS-CoV-2 infected Vero cells. Proteins from inactivated virus samples were extracted, digested with trypsin, and the resulting peptides were identified by data-dependent acquisition tandem mass spectrometry. The 101 peptides reporting for six viral proteins were specifically analyzed in terms of their analytical characteristics, species specificity and conservation, and their proneness to structural modifications. Based on these results, a shortlist of 14 peptides from the N, S, and M main structural proteins that could be used for targeted mass-spectrometry method development and diagnostic of the new SARS-CoV-2 is proposed and the best candidates are commented.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32462744</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>07</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>07</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1615-9861</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>20</Volume>
<Issue>14</Issue>
<PubDate>
<Year>2020</Year>
<Month>07</Month>
</PubDate>
</JournalIssue>
<Title>Proteomics</Title>
<ISOAbbreviation>Proteomics</ISOAbbreviation>
</Journal>
<ArticleTitle>Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.</ArticleTitle>
<Pagination>
<MedlinePgn>e2000107</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/pmic.202000107</ELocationID>
<Abstract>
<AbstractText>Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a crucial tool for fighting the COVID-19 pandemic. This dataset brief presents the exploration of a shotgun proteomics dataset acquired on SARS-CoV-2 infected Vero cells. Proteins from inactivated virus samples were extracted, digested with trypsin, and the resulting peptides were identified by data-dependent acquisition tandem mass spectrometry. The 101 peptides reporting for six viral proteins were specifically analyzed in terms of their analytical characteristics, species specificity and conservation, and their proneness to structural modifications. Based on these results, a shortlist of 14 peptides from the N, S, and M main structural proteins that could be used for targeted mass-spectrometry method development and diagnostic of the new SARS-CoV-2 is proposed and the best candidates are commented.</AbstractText>
<CopyrightInformation>© 2020 The Authors. Proteomics published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gouveia</LastName>
<ForeName>Duarte</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grenga</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gaillard</LastName>
<ForeName>Jean-Charles</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gallais</LastName>
<ForeName>Fabrice</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bellanger</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pible</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Armengaud</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
<Identifier Source="ORCID">0000-0003-1589-445X</Identifier>
<AffiliationInfo>
<Affiliation>Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols-sur-Cèze, 30200, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>ANR-17-CE18-0023-01</GrantID>
<Agency>Agence Nationale de la Recherche</Agency>
<Country>International</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>06</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Proteomics</MedlineTA>
<NlmUniqueID>101092707</NlmUniqueID>
<ISSNLinking>1615-9853</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015678">Viral Structural Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015678" MajorTopicYN="N">Viral Structural Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="Y">mass spectrometry</Keyword>
<Keyword MajorTopicYN="Y">peptides</Keyword>
<Keyword MajorTopicYN="Y">proteomics</Keyword>
<Keyword MajorTopicYN="Y">viral protein detection</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>05</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32462744</ArticleId>
<ArticleId IdType="doi">10.1002/pmic.202000107</ArticleId>
<ArticleId IdType="pmc">PMC7267140</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>S. Jiang, L. Du, Z. Shi, Emerging Microbes Infect. 2020, 9, 275.</Citation>
</Reference>
<Reference>
<Citation>D. F. Gudbjartsson, A. Helgason, H. Jonsson, O. T. Magnusson, P. Melsted, G. L. Norddahl, J. Saemundsdottir, A. Sigurdsson, P. Sulem, A. B. Agustsdottir, B. Eiriksdottir, R. Fridriksdottir, E. E. Gardarsdottir, G. Georgsson, O. S. Gretarsdottir, K. R. Gudmundsson, T. R. Gunnarsdottir, A. Gylfason, H. Holm, B. O. Jensson, A. Jonasdottir, F. Jonsson, K. S. Josefsdottir, T. Kristjansson, D. N. Magnusdottir, L. le Roux, G. Sigmundsdottir, G. Sveinbjornsson, K. E. Sveinsdottir, M. Sveinsdottir, et al., N. Engl. J. Med. 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2006100</Citation>
</Reference>
<Reference>
<Citation>H. Yao, X. Lu, Q. Chen, K. Xu, Y. Chen, L. Cheng, F. Liu, Z. Wu, H. Wu, C. Jin, M. Zheng, N. Wu, C. Jiang, L. Li, medRxiv 2020. https://www.medrxiv.org/content/10.1101/2020.04.14.20060160v1</Citation>
</Reference>
<Reference>
<Citation>L. Grenga, O. Pible, J. Armengaud, Clin. Mass Spectrom. 2019, 14, 9.</Citation>
</Reference>
<Reference>
<Citation>R. Karlsson, L. Gonzales-Siles, F. Boulund, L. Svensson-Stadler, S. Skovbjerg, A. Karlsson, M. Davidson, S. Hulth, E. Kristiansson, E. R. B. Moore, Syst. Appl. Microbiol. 2015, 38, 246.</Citation>
</Reference>
<Reference>
<Citation>Y. Charretier, O. Dauwalder, C. Franceschi, E. Degout-Charmette, G. Zambardi, T. Cecchini, C. Bardet, X. Lacoux, P. Dufour, L. Veron, H. Rostaing, V. Lanet, T. Fortin, C. Beaulieu, N. Perrot, D. Dechaume, S. Pons, V. Girard, A. Salvador, G. Durand, F. Mallard, A. Theretz, P. Broyer, S. Chatellier, G. Gervasi, M. Van Nuenen, C. A. Roitsch, A. Van Belkum, J. Lemoine, F. Vandenesch, et al., Sci. Rep. 2015, 5, 13944.</Citation>
</Reference>
<Reference>
<Citation>L. Grenga, F. Gallais, O. Pible, J. C. Gaillard, D. Gouveia, H. Batina, N. Bazaline, S. Ruat, K. Culotta, G. Miotello, S. Debroas, M.-A. Roncato, G. Steinmetz, C. Foissard, A. Desplan, B. Alpha-Bazin, C. Almunia, F. Gas, L. Bellanger, J. Armengaud, BioRxiv 2020. https://doi.org/10.1101/2020.04.17.046193</Citation>
</Reference>
<Reference>
<Citation>E. M. Hartmann, F. Allain, J. G. Gaillard, O. Pible, J. Armengaud, in Host-Bacteria Interactions (Eds: A. C. Vergunst, D. O'Callaghan), Vol. 1197, Humana Press, NY 2014, pp. 275-285.</Citation>
</Reference>
<Reference>
<Citation>Y. Perez-Riverol, A. Csordas, J. Bai, M Bernal-Llinares, S. Hewapathirana, D. J. Kundu, A. Inuganti, J. Griss, G. Mayer, M. Eisenacher, E. Pérez, J. Uszkoreit, J. Pfeuffer, T. Sachsenberg, S. Yilmaz, S. Tiwary, J. Cox, E. Audain, M. Walzer, A. F. Jarnuczak, T. Ternent, A. Brazma, J. A. Vizcaíno, Nucleic Acids Res. 2019, 47, D442.</Citation>
</Reference>
<Reference>
<Citation>B. MacLean, D. M. Tomazela, N. Shulman, M. Chambers, G. L. Finney, B. Frewen, R. Kern, D. L. Tabb, D. C. Liebler, M. J. MacCoss, Bioinformatics 2010, 26, 966.</Citation>
</Reference>
<Reference>
<Citation>B. Schilling, M. J. Rardin, B. X. MacLean, A. M. Zawadzka, B. E. Frewen, M. P. Cusack, D. J. Sorensen, M. S. Bereman, E. Jing, C. C. Wu, E. Verdin, C. R. Kahn, M. J. Maccoss, B. W. Gibson, Mol. Cell. Proteomics 2012, 11, 202.</Citation>
</Reference>
<Reference>
<Citation>S. F. Altschul, T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, D. J. Lipman, Nucleic Acids Res. 1997, 25, 3389.</Citation>
</Reference>
<Reference>
<Citation>K. Bezstarosti, M. M. Mamers, B. L. Haagmans, J. A. A. Demmers, BioRxiv 2020. https://doi.org/10.1101/2020.04.23.057810v1</Citation>
</Reference>
<Reference>
<Citation>C. Ihling, D. Tänzler, S. Hagemann, A. Kehlen, S. Hüttelmaier, A. Sinz, BioRxiv 2020. https://doi.org/10.1101/2020.04.18.047878</Citation>
</Reference>
<Reference>
<Citation>B. C. Orsburn, C. Jenkins, S. M. Miller, B. A. Neely, N. M. Bumpus, BioRxiv 2020. https://doi.org/10.1101/2020.03.08.980383</Citation>
</Reference>
<Reference>
<Citation>D. E. Gordon, G. M. Jang, M. Bouhaddou, J. Xu, K. Obernier, K. M. White, M. J. O'Meara, V. V. Rezelj, J. Z. Guo, D. L. Swaney, T. A. Tummino, R. Huettenhain, R. M. Kaake, A. L. Richards, B. Tutuncuoglu, H. Foussard, J. Batra, K. Haas, M. Modak, M. Kim, P. Haas, B. J. Polacco, H. Braberg, J. M. Fabius, M. Eckhardt, M. Soucheray, M. J. Bennett, M. Cakir, M. J. McGregor, Q. Li, et al., Nature 2020. https://www.nature.com/articles/s41586-020-2286-9</Citation>
</Reference>
<Reference>
<Citation>J. Armengaud, A. Delauney-Moisan, J. Y. Thuret, E. van Anken, D. Acosta-Alvear, T. Aragón, C. Arias, M. Blondel, I. Braakman, J.-F. Collet, R. Courcol, A. Danchin, J.-F. Deleuze, J.-P. Lavigne, S. Lucas, T. Michiels, E. R. B. Moore, J. Nixon-Abell, R. Rossello-Mora, Z. Shi, A. G. Siccardi, R. Sitia, D. Tillett, K. N. Timmis, M. B. Toledano, P. van der Sluijs, E. Vicenzi, Environ. Microbiol. 2020. https://sfamjournals.onlinelibrary.wiley.com/doi/abs/10.1111/1462-2920.15039</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Languedoc-Roussillon</li>
<li>Occitanie (région administrative)</li>
</region>
</list>
<tree>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Gouveia, Duarte" sort="Gouveia, Duarte" uniqKey="Gouveia D" first="Duarte" last="Gouveia">Duarte Gouveia</name>
</region>
<name sortKey="Armengaud, Jean" sort="Armengaud, Jean" uniqKey="Armengaud J" first="Jean" last="Armengaud">Jean Armengaud</name>
<name sortKey="Bellanger, Laurent" sort="Bellanger, Laurent" uniqKey="Bellanger L" first="Laurent" last="Bellanger">Laurent Bellanger</name>
<name sortKey="Gaillard, Jean Charles" sort="Gaillard, Jean Charles" uniqKey="Gaillard J" first="Jean-Charles" last="Gaillard">Jean-Charles Gaillard</name>
<name sortKey="Gallais, Fabrice" sort="Gallais, Fabrice" uniqKey="Gallais F" first="Fabrice" last="Gallais">Fabrice Gallais</name>
<name sortKey="Grenga, Lucia" sort="Grenga, Lucia" uniqKey="Grenga L" first="Lucia" last="Grenga">Lucia Grenga</name>
<name sortKey="Pible, Olivier" sort="Pible, Olivier" uniqKey="Pible O" first="Olivier" last="Pible">Olivier Pible</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000610 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000610 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32462744
   |texte=   Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32462744" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021